Moloney Securities Asset Management’s SOPHiA GENETICS SOPH Stock Holding History
Bought
Maintained
Sold
Other funds holding SOPH
GIM
ACM
BPC
ACM
BPCE
EDRH
Moloney Securities Asset Management's SOPH Position: Q2 2025 in Review
Moloney Securities Asset Management sold out of SOPHiA GENETICS (SOPH) in Q2 2025, closing a stake of 23,500 shares — an estimated $78K sold.
Moloney Securities Asset Management first reported a position in SOPH in Q3 2021 and held it in 15 quarters. The position peaked at $878K in Q1 2024. 32 funds tracked by Wall St. Rank hold SOPH as of Q2 2025.
- Moloney Securities Asset Management reported no remaining SOPHiA GENETICS position as of Q2 2025 after selling out during the quarter.
- Moloney Securities Asset Management sold 23,500 SOPHiA GENETICS shares in Q2 2025, an estimated $78K.
- Moloney Securities Asset Management first reported a position in SOPHiA GENETICS in Q3 2021 and held it in 15 quarters.
- Moloney Securities Asset Management's SOPHiA GENETICS position peaked at $878K in Q1 2024.
- 32 funds tracked by Wall St. Rank held SOPHiA GENETICS as of Q2 2025.
Based on Moloney Securities Asset Management's 13F filing for Q2 2025, filed 31 Jul 2025.